Skip to Content

COVID-19 is an emerging, rapidly evolving situation.

What people with cancer should know: https://www.cancer.gov/coronavirus

Guidance for cancer researchers: https://www.cancer.gov/coronavirus-researchers

Get the latest public health information from CDC: https://www.coronavirus.gov

Get the latest research information from NIH: https://www.nih.gov/coronavirus

Cancer Therapy Evaluation Program (CTEP)
Contact NExT
Show menu
Search this site
Last Updated: 05/06/20

IDB Organization Chart

John (Torrey) Sandlund, MD Min Song, PhD Kim Witherspoon, MS, MBA Jeff Moscow, MD S. Percy Ivy, MD Steven Gore, MD Charles Kunos, MD, PhD John Wright, MD, PhD Richard Piekarz, MD, PhD Helen Chen, MD Cheryl Pickett, MD, PhD Howard Streicher, MD Elad Sharon, MD

About the Branch Chief

Jeffrey A. Moscow, MD Jeffrey A. Moscow, MD, joined the Investigational Drug Branch (IDB) in 2014 after serving part time since 2012, and was appointed Branch Chief in 2018. He is a graduate of Harvard University and the Geisel School of Medicine at Dartmouth. Dr. Moscow completed his pediatric residency at the University of Texas Southwestern in Dallas and a fellowship in pediatric hematology-oncology in the Pediatric Oncology Branch, NCI. More…